0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "West Nile Drug"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
West Nile - Pipeline Insight, 2024 - Product Thumbnail Image

West Nile - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
From
EUR$2,000USDGBP
  • 2 Results (Page 1 of 1)
Loading Indicator

The West Nile Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat West Nile Virus (WNV), a mosquito-borne virus that can cause severe neurological symptoms. The market is composed of both generic and branded drugs, with the majority of sales coming from branded drugs. The market is highly competitive, with a number of companies offering similar products. The market is driven by the increasing prevalence of WNV, as well as the need for more effective treatments. As the virus continues to spread, the demand for drugs to treat it is expected to increase. Companies in the West Nile Drug market include Sanofi, GlaxoSmithKline, Merck, Pfizer, and Novartis. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more